Forged through collaboration
Previously, surgeons had to rely on medical therapy at one end of the treatment spectrum, through to invasive, bleb-dependent procedures including trabeculectomy and tube shunts at the other. Now, through close collaboration between Ellex and ophthalmic physicians, proven new minimally invasive treatment options for glaucoma are being successfully deployed around the world.
Delivering real breakthroughs
It's a pathway that's delivering real breakthroughs — particularly when it comes to reducing the use of medications as the main option in glaucoma treatment. Frequently, glaucoma patients struggle to comply with medication regimens, and many also suffer from side effects, including burning, dry eye, conjunctival hyperemia, foreign body sensation and tearing.
Real choices for physicians
Ellex technology, which includes advanced SLT Selective Laser Trabeculoplasty for diagnosis and treatment, which delivers optimum results in minimally invasive glaucoma surgery, is presenting surgeons with real choice, and who until recently could only choose between "just enough" eye drops or gold-standard but risky trabeculectomy or tube shunt procedures.
At Ellex, we're proud to be helping to shift the paradigm towards proactive glaucoma care.